Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Enzalutamide
by Most Patent Filings in the United States in 2022

The Enzalutamide top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filings Enzalutamide Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Enzalutamide is used to treat men with a certain type of prostate cancer.

Key Players

Fast-growings

Startups & Unicorns

New Entrants

Ranking Year:

2022

2021

2020

2019

2018

Region:

Global

China

India

United States

Ranking:

Most Patent Filings

Highest Patent Value

Most Patent Citation

Most Research Publications

Most Literature Citation

Most Market Reports

Most News Heat

#
Company Name
Region
Tech Topics
Total
1
Medivation Prostate Therapeutics LLC
California, United States
Drug,Medicine
Patent: 19
2
Aragon Pharmaceuticals, Inc.
California, United States
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Patent: 15
3
Bend Research, Inc.
Oregon, United States
Liposome,Bioavailability,Dosage form
Patent: 6
4
Boehringer Ingelheim Pharmaceuticals, Inc.
Connecticut, United States
Central nervous system,Medicine,Drug,
...[+2]
Patent: 5
5
Aptevo Research & Development LLC
Washington, United States
Biotechnology
Patent: 4

Who we serve

R&D Decision MakersNew Product Innovation LeaderTechnology Research AnalystsBusiness Development Professionals

Why Discovery

Technology Intelligence Data FoundationAI-powered Competitive Intelligence RadarTechnology Classification and Company Innovation Indicators

Social media

Try Discovery

Free Trial
PatSnap group products
Browse By:ABCDEFGHIJKLMNOPQRSTUVWXYZ#All topics,List of companies,Sitemap
© 2023 PatSnap. All rights reserved.Legal | Privacy policy Modern Slavery Act Transparency Statement
Page generation time: Jun 26 2025
For better visiting experience, please use PC device.X